Table 3.
Comparison between patients whose partners achieved pregnancy and those whose partners did not
| Characteristics | Pregnancy (N = 36) | Non-pregnancy (N = 60) | P value | ||||
|---|---|---|---|---|---|---|---|
| Mean ± SD | Median | Min-max | Mean ± SD | Median | Min-max | ||
| Age (years) | 35 ± 5.8 | 34.5 | 21–48 | 37 ± 6.4 | 36 | 26–56 | 0.24 |
| Vol (mL) | 3.9 ± 1.4 | 3.6 | 1.2–8 | 4.0 ± 1.7 | 3.7 | 1.2–8.9 | 0.89 |
| Conc (×106/mL) | 49.7 ± 57.0 | 33.9 | 0.001–322.8 | 53.9 ± 68.8 | 34.8 | 0.0004–399.9 | 0.92 |
| Mot (%) | 28.8 ± 20.5 | 26.9 | 0–86.1 | 25.6 ± 18.8 | 24.65 | 0–66.4 | 0.43 |
| TSC (×106/mL) | 186.3 ± 196.3 | 145.1 | 0.005–839.3 | 279.8 ± 221.0 | 126.4 | 0.003–1475 | 0.89 |
| Viability (%) | 57.6 ± 14.8 | 57.4 | 21–84.2 | 55.5 ± 20.1 | 58.8 | 1.9–86.6 | 0.85 |
| FSH (mIU/mL) | 4.9 ± 2.7 | 4.6 | 1.6–16 | 5.2 ± 3.8 | 4.3 | 1.4–18.8 | 0.73 |
| LH (mIU/mL) | 3.5 ± 1.7 | 2.8 | 1.8–7.8 | 2.9 ± 1.5 | 2.6 | 1.3–9.6 | 0.08 |
| T (ng/dL) | 487.7 ± 171.4 | 480.3 | 124–1067 | 463.6 ± 166.6 | 448 | 167–834 | 0.51 |
| SEMG+ (%) | 73.9 ± 18.5 | 73.2 | 27.6–99 | 71.9 ± 19.8 | 73.8 | 12.2–96.9 | 0.70 |
| SEMG- (%) | 26.1 ± 18.5 | 26.8 | 26.8 | 28.1 ± 19.8 | 26.2 | 3.1–87.8 | 0.70 |
| Total SEMG+ count (×106) | 127.7 ± 121.6 | 101.5 | 0–548.0 | 144.8 ± 185.3 | 77.3 | 0–1075 | 0.83 |
| Total SEMG− count (×106) | 58.6 ± 96.4 | 28.7 | 0–430.2 | 76.2 ± 143.6 | 21.0 | 0.0002–821.5 | 0.90 |
Note that only 96 of 142 patients answered the questionnaires regarding pregnancy outcomes and were included in this analysis. Mean values of each parameter for patients and control subjects were compared using Wilcoxon rank sum test